WorksheetsGYAN- GROW YOUR APTITUDE NATURALLY
Total questions: 12
Worksheet time: 9mins
As per Sept Priority what is the Azmarda/metolar tl Rx objective
30/50
50/30
40/50
50/40
which are the two brands need to be detailed to card and phy as per Sept priority
Metolar xr/Metolar TL
Azmarda/Metolar TL
Metolar TL/Metolar AM
Carloc/Metolar AM
Doctor, suffering _______________________________
___________________________ a strong protection that shields them from further damage
from a heart ailment takes a lot away from your patients. Such patients need
from a heart condition takes a lot away from your patients. Such patients need
from a heart disease takes a lot from my patients. Such patients need
from a heart condition takes a lot more away from your patients. Such patients require
How much is the BP reduction at the end of 12 weeks with Metoprolol extended release and amlodipine(Metolar AM)
20/10
15/22
25/15
24/12
As per the__________________, Telmisartan in Metolar TL has comparative effectiveness to Ramipril in reducing incidence
INTERHEART TRIAL
CARDS TRIAL
IDEAL TRIAL
ON TARGET TRIAL
Metolar TL improves ___________________ in ____________________________
insulin sensitivity , angina patients with diabetes
heart failure, angina patients with ACS
insulin sensitivity, hypertensive with diabetes
insulin sensitivity, heart failure patients with angina
Metolar TL shields against ________________________________
ischemic recurrence in stable IHD
ischemic episodes in stable IHD
ischemic episodes in MI
ischemic episodes in hypertension
Metolar TL shows reduced number and duration of ischemic episodes compared to ______________
diltiazem 60 mg
Amlodipin 5 mg
Olmisartan 40 mg
Ramipril 5 mg
as per the SHIft trial, there is_________________ in hospitalization for worsening heart failure with Ivabradine
20% reduction
22% reduction
24% increment
26% reduction
as per the SHIft trial, Ivabradin shows ________________ in CV death and hospitalization for worsening heart failure
18% reduction
18% increment
29% reduction
26% reduction
What is the indication of PLETOZ
management of intermittent subjugation
management of Intermittent claudication
management of peripheral vascular lesion
management of Berger's Disease
Dosage of Pletoz is
100/50 mg od 1 hour before food or 2 hours after food
100/50 mg bid before food or 2 hours after food
100/50 mg tid 2 hours after food
100/50 mg qid 2 hoursbefore food or 2 hours after food
